A Phase 1/2 interventional study of Low oxygen therapy (LOT) in Spinal Cord Injury, sponsored by Glen Foster. Recruiting at 2 sites in Canada. Open to participants aged 19 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-11-18.
Sponsored by Glen Foster · Phase 1/2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 204 studies in Spinal Cord Injuries with a site in Canada — 67 open to participants now, 74 under way, 4 of them phase 3. Spinal Cord Injuries · Canada.
Among the 204 studies in Spinal Cord Injuries with a site in Canada, this one is the 136th largest by planned enrollment of the 179 interventional ones that give a count, is one of 12 that started in 2025, is one of 5 in phase 1/2, reaches primary completion later than 32 of the 73 other live ones, and was the 170th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →67 of the 204 studies in Spinal Cord Injuries with a site in Canada are open now. Recruiting first, the newest first:
University of Alberta · Sites in Canada
Ages 18+
Dr. B. Catharine. Craven · Sites in Canada
Ages 18–75
University of British Columbia · Sites in Canada
Ages 19+
University of Alberta · Sites in Canada
Ages 18+
University of British Columbia · Sites in Canada
Ages 19+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 19 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
204 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 27 · Phase 3 18 · Phase 4 8
First in 1999; this study’s year is marked. 12 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10 is below the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 24 across the 179 interventional studies, 42 across the 25 observational. Of the 109 that completed or were terminated, 13 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 204 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Glen Foster as lead sponsor.
Glen Foster has 1 study filed under Spinal Cord Injuries — fewer than ten, so there is no comparison to draw.
20 of the studies in Spinal Cord Injuries with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07147296ONWARD Medical, Inc.ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury | 2026-11 |
| NCT06828653Holland Bloorview Kids Rehabilitation HospitalComparing Digitally and Traditionally Made Ankle Foot Orthoses | 2026-12 |
| NCT06691165Glen FosterImproving 24-hour Blood Pressure Stability in Spinal Cord Injury With Low Oxygen Therapy | 2026-12 |
| NCT06807528London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sIntermittent Fasting for Inflammation and Depression in Spinal Cord Injury | 2026-12-30 |
| NCT05103436University of AlbertaElectrical Stimulation for Spasticity in Spinal Cord Injury | 2026-12-31 |
Add all 20 to your calendar (.ics) → With an account.
Among the 204 studies in Spinal Cord Injuries with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study examines the effects of low oxygen therapy (LOT) on the stability of 24-hour blood pressure in persons with chronic cervical spinal cord injury.
This study will examine if brief episodes of breathing lower oxygen, termed low oxygen therapy (LOT), which has been shown to enhance autonomic nervous system activity, can improve blood pressure stability in individuals with spinal cord injury. The research team will assess 24-hour blood pressure, as well as cardiac, vascular, and autonomic function before and after a 4-day LOT treatment intervention. This study will advance current understanding of treatments to mitigate cardiovascular disease risk in people with spinal cord injuries.
Spinal cord injury (SCI) interrupts signals travelling down from the brain to the rest of the body below the level of the injury. The loss of nerve connections involved in cardiovascular control results in blood pressure instability. This can lead to sudden drops in blood pressure, such as when shifting upright or during transfers, or sudden increases during autonomic dysreflexia. These swings in blood pressure are linked to a nearly 4-fold increase in the risk of cardiovascular disease in people with SCI.
Repeated, brief exposure to breathing lower levels of oxygen, termed low oxygen therapy, has been shown to stimulate adaptation in the nervous system. This neuroplasticity increases the activity of cardiovascular control circuits, and has been shown to increase blood pressure in able-bodied individuals. Similar effects on respiratory and motor function in people with SCI, but the effects on the cardiovascular system have not been studied in this population.
This study will test the effects of a 4-day low oxygen therapy intervention on 24-hour blood pressure stability in people with chronic cervical SCI. By assessing mechanisms of cardiac, vascular, and autonomic function, this study aims to improve current understanding of the therapeutic potential of low oxygen therapy to mitigate cardiovascular disease risk in SCI.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants with chronic cervical spinal cord injury will undergo a 4-day low oxygen therapy intervention. Measurements will first be taken at least three days before the beginning of the intervention to establish baseline characteristics, immediately before and after the first day of the intervention to assess the acute response to the intervention, and on the first and fourth days after the end of the intervention to assess persistent effects and washout.
Drug: Low oxygen therapy (LOT)
Participants will breathe variable concentrations of inspired oxygen, carbon dioxide, and nitrogen. The concentrations will be adjusted on a breath-by-breath basis to maintain end-tidal targets. Each daily session of the intervention will consist of forty 1-minute intervals. Each 1-minute interval will consist of 40 seconds of hypercapnic hypoxia, increasing the partial pressure of end-tidal carbon dioxide by +4 mmHg and decreasing the partial pressure of end-tidal oxygen to 45 mmHg, followed by 20 seconds in simulated room air to return to baseline carbon dioxide and oxygen levels.
Also known as: Intermittent hypoxia
Change in 24-hour blood pressure
Mean arterial blood pressure (mmHg), averaged across 24 hours
Time frame: Change from baseline of 24-hour mean arterial blood pressure at 1-day post-intervention
Change in 24-hour blood pressure stability
Mean arterial blood pressure (mmHg), standard deviation across 24 hours
Time frame: Change from baseline of the standard deviation of 24-hour mean arterial blood pressure at 1-day post-intervention
Change in left-ventricular contractility
Indices of load-independent pressure generation during systole: Estimated end-systolic elastance (mmHg/ml); end-systolic pressure-volume relationship slopes (mmHg/ml)
Time frame: Change from baseline of left ventricular contractility indices immediately after the first intervention session, and at 1-day and 4-days post-intervention
Change in baroreflex gain
Indices of baroreflex sensitivity: Relationship of systolic blood pressure against subsequent R-R interval duration during Valsalva Maneuver phases II and IV (ms/mmHg); spectral power of low-frequency resting blood pressure variability
Time frame: Change from baseline of baroreflex gain indices immediately after first intervention session, and at 1-day and 4-days post-intervention
Change in circulating catecholamines
Venous plasma concentrations of norepinephrine and epinephrine (mmol/L)
Time frame: Change from baseline of circulating catecholamines immediately after first intervention session, and at 1-day and 4-days post-intervention
Change in cerebral neurovascular coupling and autoregulation
Middle and posterior cerebral artery blood flow velocity (cm/s)
Time frame: Change from baseline of the responses of cerebral blood flow indices during a visual stimulus and head-up tilt immediately after first intervention session, and at 1-day and 4-days post-intervention
Change in renal filtration function
Humoral renal biomarkers (e.g., serum creatinine)
Time frame: Change from baseline in renal biomarkers and blood flow at rest immediately after first intervention session, and at 1-day and 4-days post-intervention
Change in flow-mediated dilation
Brachial artery flow-mediated dilation following 5-minute forearm blood flow occlusion (mm)
Time frame: Change from baseline in flow-mediated dilation immediately after first intervention session, and at 1-day and 4-days post-intervention
Change in tonic peripheral chemoreflex activity
Magnitude of hyperoxic ventilatory depression (L/min)
Time frame: Change from baseline in the magnitude of ventilatory depression in hyperoxia immediately after first intervention session, and at 1-day and 4-days post-intervention
Change in renal vascular function
Renal artery blood flow velocity (cm/s)
Time frame: Change in renal blood flow velocity from baseline during the first and final hypoxia cycles on the first session of the intervention
Plan to share: No
Started Oct 2025 (actual). Primary completion is estimated for Dec 2026, 14 months after the start.
Of 24 phase 1/2 interventional studies under Spinal Cord Injuries, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 60. This study's planned 14 months is below that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.